Rani Therapeutics Holdings, Inc. logo

Rani Therapeutics Holdings, Inc.

NASDAQ:RANI

Overview | Financials
Company Name Rani Therapeutics Holdings, Inc.
Symbol RANI
Currency USD
Price 2.62
Market Cap 139,923,885
Dividend Yield 0%
52-week-range 1.82 - 8.75
Industry Biotechnology
Sector Healthcare
CEO Mr. Talat Imran
Website https://www.ranitherapeutics.com

An error occurred while fetching data.

About Rani Therapeutics Holdings, Inc.

Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed Phase I

Related Stocks

Inogen, Inc. logo

Inogen, Inc.

INGN

11.3 USD

Pharvaris N.V. logo

Pharvaris N.V.

PHVS

19.12 USD

Gossamer Bio, Inc. logo

Gossamer Bio, Inc.

GOSS

0.91 USD

Relmada Therapeutics, Inc. logo

Relmada Therapeutics, Inc.

RLMD

2.4 USD

Kiniksa Pharmaceuticals, Ltd. logo

Kiniksa Pharmaceuticals, Ltd.

KNSA

24.93 USD

PMV Pharmaceuticals, Inc. logo

PMV Pharmaceuticals, Inc.

PMVP

1.5 USD

Eagle Pharmaceuticals, Inc. logo

Eagle Pharmaceuticals, Inc.

EGRX

4.25 USD

Financials

Numbers are in millions USD

Numbers are in millions USD